Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

Mona Aarenstrup Karlsen, Noreen Sandhu, Claus Høgdall, Ib Jarle Christensen, Lotte Nedergaard, Lene Lundvall, Svend A Engelholm, Anette T Pedersen, Dorthe Hartwell, Magnus Christian Lydolph, Inga Alice Laursen, Estrid V S Høgdall

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    193 Citationer (Scopus)

    Abstract

    Diagnostic factors are needed to improve the currently used serum CA125 and risk of malignancy index (RMI) in differentiating ovarian cancer (OC) from other pelvic masses, thereby achieving precise and fast referral to a tertiary center and correct selection for further diagnostics. The aim was to evaluate serum Human Epididymis protein 4 (HE4) and the risk of ovarian malignancy algorithm (ROMA) for these purposes.
    OriginalsprogEngelsk
    TidsskriftGynecologic Oncology
    Vol/bind127
    Udgave nummer2
    Sider (fra-til)379-83
    Antal sider5
    ISSN0090-8258
    DOI
    StatusUdgivet - 2012

    Citationsformater